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Abstract 
INTRODUCTION: Dobutamine stress echocardiography (DSE) and myocardial perfusion scan are the commonly 
used modalities to detect viable myocardium. DSE is comparatively cheaper and widely available but has a lower 
sensitivity.  
AIM: We aimed to compare contrast-enhanced low-dose dobutamine echocardiography (LDDE) and gated 
99mTc-sestamibi myocardial perfusion scan (MPS) for the degree of agreement in the detection of myocardial 
viability.  
METHODS: We studied 850 left ventricular segments from 50 patients (42 men, mean age 55.5 years), with 
coronary artery disease and left ventricular systolic dysfunction (ejection fraction < 40%), using contrast-enhanced 
LDDE and 99mTc-Sestamibi gated SPECT. Segments were assessed for the presence of viability by both 
techniques and head to head comparisons were made. 
RESULTS: Adequate visualisation increased from 80% in unenhanced segments to 96% in contrast-enhanced 
segments. Of the total 850 segments studied, 290 segments (34.1%) had abnormal contraction (dysfunctional). 
Among these, 138 were hypokinetic (16.2% of total), 144 were severely hypokinetic or akinetic (16.9% of total), 
and 8 segments were dyskinetic or aneurismal (0.9% of total). Among 151 segments considered viable by 
technetium, 137 (90.7%) showed contractile improvement with dobutamine; in contrast, only 8 of the 139 
segments (5.7%) considered nonviable by technetium had a positive dobutamine response. The per cent of 
agreement between technetium uptake and a positive response to dobutamine was 78.6% with kappa = 0.63, 
suggestive of a substantial degree of agreement between the two modalities. 
CONCLUSION: Use of contrast-enhanced LDDE significantly increased the adequate endocardial border 
visualisation. Furthermore, this study showed a strong degree of agreement between the modalities in the 
detection of viable segments. So, contrast-enhanced LDDE appears to be a safe and comparable alternative to 
MPS in myocardial viability assessment. 
 
 
 
 
 
Introduction 
 
Left ventricular dysfunction associated with 
coronary artery disease (CAD) is a common cause of 
morbidity and mortality. However, reports show that > 
50% of such patients may have viable myocardium 
[1]. Revascularization improves left ventricular 
ejection fraction (LVEF), heart failure symptoms and 
prognosis predominantly in patients with viable 
myocardium [2], [3], [4], [5], [6], [7], [8]. Though some 
recent studies provided contrary results, they had 
several significant limitations and confounding factors 
[9], [10].  
Based on robust evidence on viability 
assessment, American Heart Association (AHA) has 
given class IIa recommendation for non-invasive 
imaging in patients with heart failure who have known 
CAD and no angina [11]. Guidelines from other 
societies also recommend detection of viability in the 
diagnostic workup of patients with CAD and severe 
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ventricular dysfunction [12], [13].
 
 
Most widely available and commonly used 
methods for this purpose are dobutamine stress 
echocardiography (DSE) and SPECT. Tc-99m 
sestamibi is the most widely used tracer in SPECT. 
The main limitations of SPECT include, higher cost 
compared to echocardiography, limited spatial 
resolution, poor availability, potential difficulty in 
interpreting results in patients with balanced 
myocardial ischemia (3-vessel disease), and risk of 
radiation. Higher cost and limited availability are the 
most important limitations in resource-poor countries 
like India. Results of DSE are immediately available, 
can be done bedside in sicker patients significantly 
supporting rapid patient management. An obvious 
advantage is the availability of ancillary information 
about chamber sizes and function, valves, pericardial 
effusion, aortic root disease. Additional parameters of 
viability can also be assessed like strain imaging, 
Doppler studies, and end-diastolic wall thickness 
(EDWT). However, in patients with chronic ischemic 
ventricular dysfunction, DSE has higher specificity 
(78% vs 65%) but a slightly lower sensitivity (81% vs 
83%) compared to SPECT [14], [15], [16]. 
Recent advances in echocardiographic 
imaging have, however, significantly increased the 
sensitivity and interobserver agreement for the 
detection of coronary artery disease. These include 
harmonic imaging and LV opacification with contrast 
agents. Contrast-enhanced imaging, enable better 
visualisation of the endocardial border and a more 
reliable assessment of contractile function even in 
patients difficult to image with fundamental imaging. 
Therefore, contrast-enhanced imaging has been 
regularly used in DSE for myocardial detection 
ischemia in cases with ≥ 2 poorly visualised segments 
as recommended by various guidelines [17], [18], [19]. 
However, contrast enhancement has not been used in 
the setting of viability assessment by low dose 
dobutamine echocardiography (LDDE). Hence 
combining contrast with LDDE to increase sensitivity 
for viability assessment appears an attractive option. 
However, there is no head to head trial comparing the 
sensitivity of contrast-enhanced dobutamine stress 
echocardiography against myocardial perfusion 
SPECT. This study aimed to assess the degree of 
agreement between the two methods in detecting 
viability in dysfunctional myocardial segments.  
 
 
Material and Methods 
 
Study population  
This was a single centre, double-blinded, a 
comparative study between DSE and Tc-SPECT. The 
study period was from May 2014 to December 2016, 
carried out in the department of cardiology, Jawaharlal 
Institute of Postgraduate Medical Education and 
Research (JIPMER), Puducherry, India. Fifty 
consecutive patients with chronic coronary artery 
disease and impaired left ventricular systolic function 
(ejection fraction, EF < 40% at rest) without chest pain 
were included in the study. The study was conducted 
according to the Helsinki Declaration and the Good 
Clinical Practice Guidelines. Written informed consent 
was obtained from all patients. Ethical approval for the 
study protocol was obtained from the Ethics 
Committee of JIPMER.  
 
Study design 
The patients included in the study first 
underwent low dose dobutamine stress 
echocardiography (LDSE) with proper safety 
precautions in the cardiology department. As per 
protocol, the contrast agent was administered to 
patients both before and after stress, for better 
visualisation of wall motion abnormality. Dobutamine 
infusion was then continued to a high dose to attain 
peak stress. At peak stress, technetium was injected, 
and the patient was shifted for stress SPECT in the 
nuclear medicine department of the institute. Rest 
SPECT was done on a separate day. Two-day 
rest/stress protocol was used for SPECT study [20], 
[21], [22]. Both procedures were done in short interval 
maximum one week apart. 17-segment heart model, 
as recommended by ACC/AHA, was used for defect 
localisation and comparison between two modalities 
[23]. The cardiologist doing the LDSE was blinded to 
SPECT results and vice-versa.  
 
Dobutamine stress echocardiography 
protocol [17], [18], [19] 
Beta-blockers, CCBs and nitrates were 
stopped at least 2 days before DSE. The subjects 
were kept fasting for at least 4 hours. 2 ml of SonoVue 
ultrasound contrast (Sulphur Hexafluoride 
microbubbles, Bracco, Switzerland) was used for LV 
opacification at baseline and after dobutamine stress 
in all patients. The contrast was used with harmonic 
imaging and low MI settings (Mechanical Index, 0.15 
to 0.3). Four views were acquired in all patients: apical 
four chamber and two chamber views, parasternal 
short axis and long axis (or long apical axis) views. 
The frame rate was kept > 25 frames per second. The 
initial infusion of dobutamine was 2.5 μg/kg/min and 
gradually increased to 5, 7.5, 10, and 20 μg /kg/min, 
as required. Each dose was maintained for up to five 
minutes. An increase in heart rate by 10% was taken 
as end-point for completion of low dose dobutamine 
protocol. After completing the low dose protocol 
higher dosages of dobutamine (30 and 40 
mcg/kg/min) was given to achieve peak stress so that 
stress SPECT could be done. All patients were 
continuously monitored for at least 30 min along with 
all emergency equipment.  
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All image acquisition and analysis were done 
by Philips IE33 system (Phillips Medical Systems, 
Andover, MA, USA), using 5 MHz probes. Off-line 
visual assessment of endocardial excursion and wall 
thickening was used for analysis. Function in each 
segment is graded at rest and with stress as normal, 
hypokinetic, akinetic/severely hypokinetic, dyskinetic, 
or aneurismal. Segments were considered 
dysfunctional when the wall motion score was 2 or 
more. Viability was considered to be present in a 
dysfunctional segment when there was an 
improvement in function by at least one grade, except 
improvement from dyskinesia to akinesia.  
 
Myocardial perfusion scan protocol [20], 
[21], [22]
 
The stress SPECT was done on the same 
day of DSE, by using the ongoing dobutamine infusion 
to achieve peak stress. The radiotracer (Tc-99m) was 
injected intravenously at 1 minute into peak stress, 
and dobutamine infusion was continued for 2 minutes 
after the radiotracer injection. 30 min after injection of 
99mTc-sestamibi, the patients were required to eat a 
fatty snack to accelerate hepatobiliary excretion of the 
radiotracer. For stress imaging, 555 MBq-1.11 GBq 
(15 – 30 mCi) was injected at peak stress. Gated 
SPECT was then performed from 30-60 minutes after 
injection. On a separate day rest, myocardial 
perfusion scan was done. For rest imaging, 555 MBq 
– 1.11 GBq (15-30 mCi) was injected at rest. 5 mg of 
sublingual nitrate was taken by patients 10 minutes 
before 9mTc-sestamibi injection. Gated SPECT was 
then performed within 45-60 min after injection.  
The images were displayed as short axis, 
vertical and horizontal axes sections. Uptake was 
measured semiquantitatively based on the visual 
interpretation of colour scale. Segments were divided 
into 5 categories: 0 = normal perfusion, 1 = slightly 
reduced tracer uptake (> 75%), 2 = moderately 
reduced tracer uptake (50% t o75%), 3 = severely 
reduced tracer uptake (30% to 50%), and 4 = absent 
tracer uptake (< 30%). As a general rule, segments 
with rest score of 0 (normal perfusion) and 1 (slight 
reduction in counts) are considered viable. Segments 
with rest score of 2 (moderately decreased perfusion) 
are considered to represent a combination of viable 
and nonviable myocardium. In dysfunctional 
segments, perfusion was considered preserved when 
activity was 50% or more (score 0, 1 or 2). 
  
Statistical analysis 
Continuous variables are expressed as mean 
± SD and categorical variables as the absolute values 
and percentages. A chi-squared test was used to 
compare the statistical parameters of this technique. 
The correlation between the two tests for the 
assessment of myocardial segment viability was 
expressed as per cent agreement and value of Kappa 
(k). A p-value < 0.05 was considered statistically 
significant. Statistical analysis was performed using 
an SPSS software version 18.0. 
 
 
Results 
 
In total, 50 patients constituted the final study 
population. Mean age was 55.5 ± 10.7 years and 42 
were males (84%). The mean LVEF by 
echocardiography, calculated by Simpson’s method, 
was 32 ± 4.6% (range = 21-40). The mean LVEF 
calculated by gated-SPECT was 29.5 ± 4.6% (range = 
20-42). Twenty-seven patients had diabetes (54%), 21 
were hypertensive (42%), 20 were a smoker (40%), 
and dyslipidaemia was seen in 19 patients (38%). 
Coronary artery disease was defined as > 50% 
diameter stenosis. Single vessel disease was seen in 
13 patients (26%), double vessel disease in 18 
patients (36%), triple vessel disease in 21 patients 
(42%), and left main disease was found in 9 patients 
(18%), (Table 1).  
Table 1: Baseline characteristics of the study population 
Variables  
Age 55.5 ± 10.7 years (range = 25-76 years) 
Male 42 (84)   
LVEF 32 ± 4.6% (range = 21-40) 
CV risk factors  
Diabetes 27 (54% 
Hypertension 21 (42)  
Smoker 20 (40) 
Dyslipidemia 19 (38) 
Past ACS 24 (48)  
Severity of CAD  
SVD 13 (26) 
DVD 18 (36) 
TVD 21 (42) 
M disease 9 (18)  
Values shown represent numbers (percentages) and mean ± SD; LVEF, Left ventricular 
ejection fraction; CV, Cardiovascular; ACS, Acute coronary syndrome; CAD, Coronary 
artery disease; SVD, Single-vessel disease; DVD, Double-vessel disease; TVD, Triple-
vessel disease; LM, Left-main. 
 
Low-Dose Dobutamine Stress 
Echocardiography (LDDE) 
A total of 850 segments from 50 patients were 
analysed, based on the 17 segment model of heart 
both LDDE and Tc-SPECT (Figure 1). Out of 850 
segments, 170 segments were inadequately 
visualised at rest in unenhanced DSE.  
 
Figure 1: A 17-segment model of heart recommended by AHA 
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Adequate visualisation increased from 80% in 
unenhanced segments to 96%, in contrast, enhanced 
segments. Overall 4 patients (8%) had uninterpretable 
DSE in unenhanced images, with the use of contrast 
all studies became interpretable (Figure 2). Regional 
contractile function, as assessed by resting two-
dimensional echocardiography, demonstrated normal 
contraction in 560 segments (65.8%) and abnormal 
contraction (dysfunctional) in 290 segments (34.1%). 
Of 290 dysfunctional segments, 138 were hypokinetic 
(16.2% of total), 144 were severely hypokinetic or 
akinetic (16.9% of total), and 8 segments were 
dyskinetic or aneurismal (0.9% of total) (Figure 2). 
 
Figure 2: Representative still images showing significant 
improvement in visualisation of the endocardial border by use of 
contrast agent; A) without contrast; B) with SonoVue contrast 
 
Dysfunctional segments were evaluated for 
the presence of contractile reserve, defined as an 
improvement of wall motion score by 1 grade or more. 
Of the 290 dysfunctional segments, 134 (46.2%) were 
viable and 156 (53.8%) nonviable by LDDE. Viability 
was found in 108/138 (78.2%) of hypokinetic and 
26/144 (18%) severely hypokinetic/akinetic regions. 
All 8 dyskinetic/aneurismal segments were nonviable 
(Figure 3). 
 
Figure 3: Distribution of regional contractile function assessed by 
echocardiography at rest 
 
99mTc-Sestamibi gated SPECT  
Significant LV dilatation was seen in 13 
patients (26%) and transient ischemic dilatation found 
in 5 patients (10%). Of the 290 dysfunctional 
segments, 151 (52%) were viable and 139 (48%) 
nonviable. Results of resting two-dimensional 
echocardiography and MPS showed that 119/138 
(86%) of hypokinetic, 28/144 (19.4%) of severely 
hypokinetic and 4/8 (50%) of aneurismal regions were 
viable. Of the non-viable region, perfusion was grade 
3 in 70% patients and grade 4 in 30% of patients. Of 
the 151 viable segments by rest MPS, 129 segments 
showed ischemia on stress (85.4%).  
 
The relation between LDDE and SPECT  
The number of segments with regional wall 
motion abnormalities (RWMA) that were considered 
viable by technetium was greater than the number of 
segments showing a contractile improvement in 
response to dobutamine (52% versus 46.2%). 
However, the difference was not significant (p = 0.31). 
A significant relation was observed between 
technetium uptake and response to dobutamine. 
Among 151 segments considered viable by 
technetium, 137 (90.7%) showed contractile 
improvement with dobutamine; in contrast, only 8 of 
the 139 segments (5.7%) considered nonviable by 
technetium had a positive dobutamine response. 
On the contrary, we observed that 1.7% 
(5/290) of dysfunctional segments showed contractile 
reserve according to DSE, but did not show 
technetium uptake. The rate of agreement between 
technetium uptake and a positive response to 
dobutamine was 78.6%. The value of kappa for the 
degree of agreement between the two modalities was 
found to be 0.63. This corresponds to a substantial 
degree of agreement between the two tests. 
 
 
Discussion 
 
In patients with severe coronary artery 
disease and a low LVEF, the evaluation of viability in 
regions with chronic contractile dysfunction has been 
shown to predict improvement of function after 
revascularization [2], [3], [4], [5], [6], [7], [8], [24], [25]. 
The current study was done to compare the most 
widely available and commonly used modalities, i.e. 
dobutamine stress echocardiography and 99mTc-
sestamibi imaging for the assessment of viable 
myocardium. 
A head-to-head comparison of the individual 
segments in this study showed a 78.6% agreement 
between contrast-enhanced low-dose dobutamine 
stress echocardiography and ECG gated myocardial 
SPECT. Various direct comparisons of nuclear 
imaging and LDDE have reported a fair degree of 
agreement between the techniques. Panza et al. 
reported an agreement between 201Tl imaging and 
Verna et al. Contrast Enhanced Low-Dose Dobutamine Stress Echocardiography with 99mTc-Sestamibi Single-Photon Emission Computed Tomography 
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low dose dobutamine echocardiography of 68% [26].
 
The disagreement in their study was also mainly 
related to segments with viability on nuclear imaging 
but without functional improvement on 
echocardiography. The largest head-to-head 
comparison was made by Bax et al., which included 
114 patients who underwent resting perfusion imaging 
with 99mTc-tetrofosmin and low-dose dobutamine 
echocardiography. The agreement rate reported 
between the techniques was 72% [27]. 
Moreover, a recent study to has reported with 
an agreement rate of 77% between LDDE and gated-
SPECT with low dose dobutamine infusion [28]. 
However, Bax et al., compared LDDE with 99mTc-
tetrofosmin and Panja et al., compared with thallium. 
In our settings (India), there is poor availability of 
thallium and 99mTc-tetrofosmin is not available, 
whereas, our study is more relevant in Indian setting 
because we have shown a substantial degree of 
agreement using 99m-technetium.  
 It has been seen that poor-quality images 
may occur in up to 30% of patients due to challenges 
imposed by excessive cardiac motion due to 
hyperventilation and tachycardia and in up to 10% due 
to patient-related factors like obesity and lung 
disease. Moreover, suboptimal studies result in 
increased interobserver variability and less 
reproducibility. Several recent studies have assessed 
whether better endocardial border visualisation by left 
ventricular opacification improves the accuracy of 
stress echocardiography for diagnosis of coronary 
artery disease. In the OPTIMIZE trial, which included 
108 patients, the use of a contrast agent improved the 
percentage of segments adequately visualised at 
baseline (from 72 ± 24% to 95 ± 8%) [29]. Similar 
results were found in this study. Out of 850 segments, 
170 segments were inadequately visualised at rest in 
unenhanced DSE. With the use of contrast, adequate 
visualisation increased from 80% in unenhanced 
segments to 96% contrast-enhanced segments. 
Overall 4 patients (8%) had uninterpretable DSE in 
unenhanced images, with the use of contrast all 
studies became interpretable.  
Discordance was observed between the two 
methods in both hypokinetic and akinetic segments. 
Put in other words, for the same dysfunctional 
segments gated SPECT showed viability more often 
than LDDE. Similar results were reported by Panza et 
al., and Bax et al. who found that detection of viability 
by nuclear scan was more frequent than DSE. This 
difference is considered to be due to the difference in 
mechanisms of viability detection by the two methods. 
A higher degree of myocyte functional integrity is 
required for contractile reserve than radiotracer 
uptake by the cells [30]. We observed that 1.7% 
(5/290) of dysfunctional segments showed contractile 
reserve according to DSE, but did not show 
technetium uptake. Similarly, Panza et al., reported 
2% (6/311) of dysfunctional segments without 
perfusion, but they thought it to be due to the error 
inherent in the comparison of the two techniques. 
However, this is more likely attributable to areas with 
non-transmural myocardial infarction, as described by 
Armstrong [31]. 
In this study,
 
we reported the safety, and 
diagnostic accuracy of contrast-enhanced dobutamine 
stress echocardiography in a population of patients 
with known coronary artery disease. In agreement 
with the earlier reports, the technique was well 
tolerated by all patients, and in no case did the study 
have to be discontinued because of occurrence of 
serious side effects due to contrast (SonoVue) or 
dobutamine [32].
 
The echocardiographic approaches 
are attractive because there is no ionising radiation, is 
safe, widely available, low cost, shorter imaging time, 
portable, immediate availability of the results, 
additional parameters of viability (strain, Doppler, 
EDWT), availability of ancillary information about 
cardiac structures. None of the previous head to head 
trial used contrast-enhanced LDDE for comparison. 
This is extremely important for resource developing 
countries like India where echocardiography is more 
readily available and a significantly lower cost as 
compared to SPECT. This study demonstrated a good 
agreement between contrast-enhanced low dose 
dobutamine stress echocardiography and Tc-SPECT 
for the myocardial detection viability. Therefore, 
contrast-enhanced LDDE can be used for viability 
detection with a good level of confidence. 
In conclusion, the use of contrast agent 
significantly increases the adequate endocardial 
border visualisation and increases interpretability of 
images. Our study demonstrated a substantial degree 
of agreement between contrast-enhanced low dose 
dobutamine stress echocardiography and Tc-99m 
SPECT for the detection of contractile reserve in 
infarcted areas. So, contrast-enhanced LDDE appears 
to be a safe and comparable alternative to MPS in 
myocardial viability assessment.  
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